|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Robust clustering in high dimensional data using statistical depths显示文摘 | DING Yuanyuan DANG Xin PENG Hanxiang | | 0，，7： | 1 |
| 2 | Outlier detection with the kernelized spatial depth function显示文摘 | Chen Yixin Dang Xin Peng Hanxiang | 2009 | IEEE Transactions on Pattern Analysis and Machine Intelligence2009，31，2： | 1 |
| 3 | Outlier Detection with the Kernelized Spatial Depth Function显示文摘 | Chen Yixin Dang Xin Peng Hanxiang | 2009 | Pattern Analysis'' and Machine Intelligence2009，31，2： | 1 |
| 4 | Outlier detection with the Kemelized spatial depth function 显示文摘 | CHEN YIXIN DANG XIN PENG HANXIANG | 2009 | IEEE Transactions on Pattern Analysis and Machine Intelligence2009，31，11： | 1 |
| 5 | Out-lier detection with the kernelized spatial depth function 显示文摘 | CHEN Yixin DANG Xin PENG Hanxiang | 2009 | Pattern Analysis and Machine Intelligence2009，31，2： | 1 |
| 6 | Robust clustering in high dimensional data using statistical depths 显示文摘 | DING Yuanyuan DANG Xin PENG Hanxiang | 2007 | BMC Bioinformatics2007，8，7： | 1 |
| 7 | Pancreatic steatosis and its correlation with clinicopathological features in patients with pancreatic neuroendocrine neoplasms显示文摘Background and objective:The incidence of pancreatic neuroendocrine neoplasms(pNENs)has been increasing year by year,and pancreatic steatosis has been paid more and more attention to by clinicians.Our study aims to reveal the correlation between pancreatic steatosis,clinicopathological parameters,and the prognosis of patients with pNENs.Methods:The clinicopathological data of patients with pNENs who underwent surgical resections in our institution from January 2013 to May 2022 were retrospectively analyzed.The mean computed tomography(CT)values of the pancreas and spleen were used to assess the severity of the pancreatic steatosis.Pearson Chi-square test,T test,Mann Whitney U test,Univariate Cox re-gression,and Multivariate Cox regression were used to explore the relationship between pancreatic steatosis and age,sex,body mass index,tumor type,tumor location,tumor stage,blood lipid,prognosis,and other factors.Results:A total of 122 patients were included in our study,and 19.67%have pancreatic steatosis.The incidence of pancreatic steatosis was significantly higher in patients with fatty liver than in patients without fatty liver(36.8%vs 16.5%,P=.04).In insu-linoma,the incidence of pancreatic steatosis in elderly patients was significantly higher than in young and middle-aged patients(41.7%vs 9.3%,P=.025).There was no significant difference in lipid levels between the pancreatic steatosis group and the non-pancreatic steatosis group(P>.05).Kaplan-Meier curves show that the prognosis of stage III/IV patients was significantly worse than that of stage I/II patients(P<.001).However,there was no significant difference in prognosis between patients with and without pancreatic steatosis(P=.404).Conclusion:The incidence of pancreatic steatosis was significantly higher in those with fatty liver than those without fatty liver.There is a high incidence of pancreatic steatosis in elderly patients with insulinoma.American Joint Committee on Cancer(AJCC)stage,but not pancreatic steatosis,significantly affected the prognosis of patients with pNENs. | Yongzheng Li Jian Yang Zhiyao Fan Peng Dong Jingjuan Hu Shujie Liu Yufan Meng Changhao Gao Xin Gao Chaoyu Pang Hanxiang Zhan | 2023 | Journal of Pancreatology2023，6，2： | 0 |
| 8 | An unrecognized undifferentiated tumor of the pancreas:a case report显示文摘SMARCA4-deficient tumors are gaining attention,and this type of tumor is highly malignant with a poor prognosis.The frequency of SMARCA4 deletion varies in different tumors.However,it has never been identified in the pancreas.A 67-year-old woman pre-sented with upper abdominal pain lasting for half a month.Computed tomography indicated a space-occupying lesion in the head of the pancreas,considered a malignant tumor.Further Endoscopic ultrasound fine-needle aspiration was performed and report-ed as SMARCA4-deficient undifferentiated pancreatic tumor.The patient received no treatment and survived only two and a half months from diagnosis to death.We are the first to report SMARCA4-deficient pancreatic undifferentiated tumor in which this new tumor entity presents with poorer overall survival.We also summarized the advances of SMARCA4 in oncology and treatment. | Chaoyu Pang Zhiyao Fan Peng Su Hanxiang Zhan | 2023 | Journal of Pancreatology2023，6，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员